C.A.T.T. Trial: the side effects
Comparing two drugs, avastin and lucentis, for macular degeneration: this the aim of the C.A.T.T. trial. However, the study has also brought to light some concerning side effects of the avastin drug.
Comparing two drugs, avastin and lucentis, for macular degeneration: this the aim of the C.A.T.T. trial. However, the study has also brought to light some concerning side effects of the avastin drug.
Retinal diseases: the CATT Study and the emerging treatments
Retinal diseases: patients and quality of life
it
Prof. Filippo Cruciani
Introduction - Susanna Petruni TG1 (RAI)
it
Diabetic macular edema
it
Prof. Francesco Bandello
The impact of retinal diseases
it
Prof. Filippo Cruciani
Hyper vision and blindness
it
Prof. Filippo Cruciani
Macular Degeneration: impact on quality of life
it
Prof. Filippo Cruciani
Retinal diseases and economic social impact
it
Prof. Filippo Cruciani
Macular degeneration does not cause blindness
it
Prof. Francesco Bandello
Age related Macular Degeneration: the treatments
it
Prof. Francesco Bandello
C.A.T.T. Trial: the side effects
it
Prof. Francesco Bandello
Economic savings or minimum side effects: a difficult choice
it
Prof. Francesco Bandello
Questions & answers - 1st part
it
Questions & answers - 2nd part
it
Questions & answers - 3rd part
it